The Rapid Response® COVID-19 Antigen Rapid Test detects specific SARS-CoV-2 antigens in nasal or nasopharyngeal specimens. It offers a sensitivity of 90.20% for nasal specimens and 95.8% for nasopharyngeal specimens, providing results in just 15 minutes. It is Health Canada approved.
The Rapid Response® COVID-19 Antigen Rapid Test is designed for the quick and accurate detection of SARS-CoV-2 antigens, which indicate an active COVID-19 infection. This test can be used with nasal or nasopharyngeal specimens, with demonstrated sensitivities of 90.20% for nasal specimens and 95.8% for nasopharyngeal specimens. The test delivers results in 15 minutes, making it a convenient and efficient tool for rapid COVID-19 screening. Approved by Health Canada, this test ensures reliable performance and adherence to regulatory standards, supporting timely and effective COVID-19 detection and management.
| PKG | 25/bx |
|---|
Reviews
There are no reviews yet.